Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Feroglobin is a branded combination dietary supplement formulated primarily to support healthy blood formation and prevent or treat iron deficiency. It contains iron (as ferrous fumarate or ferric ammonium citrate), along with cofactors such as folic acid, vitamin B12 (cyanocobalamin), vitamin B6, zinc, copper, and sometimes additional B vitamins. The mechanism of action is based on providing essential nutrients required for the synthesis of hemoglobin and red blood cells. Iron is crucial for oxygen transport in the body; folic acid and vitamin B12 are necessary for DNA synthesis during red cell production; zinc and copper act as cofactors in various enzymatic processes related to hematopoiesis. The product uses a slow-release system designed to be gentle on the stomach while ensuring gradual absorption of nutrients[4][6][8]. It is indicated for individuals at risk of iron deficiency anemia due to menstruation, pregnancy, growth spurts in children (liquid formulation), chronic disease states, or increased physiological demand[2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Feroglobin.